TY  - JOUR
AU  - Martínez-Chinchilla, Carlos
AU  - Vazquez-Montero, Lucía
AU  - Palazón-Carrión, Natalia
AU  - Fernández-Román, Isabel M
AU  - López-Barba, José
AU  - de la Cruz-Merino, Luis
AU  - Rodríguez-Baño, Jesús
AU  - Palacios-Baena, Zaira R
PY  - 2022
DO  - 10.3389/fimmu.2022.860891
UR  - http://hdl.handle.net/10668/20582
T2  - Frontiers in immunology
AB  - Immunosuppressant conditions such as hematological malignancies increase the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. It has been described in the literature that patients on anti-CD20 maintenance therapies for...
LA  - en
KW  - COVID-19
KW  - SARS-CoV-2
KW  - anti-CD20
KW  - case report
KW  - immunocompromised
KW  - lymphoma
KW  - rituximab
KW  - Antibodies, Monoclonal
KW  - Humans
KW  - Immunocompromised Host
KW  - Immunosuppressive Agents
KW  - Lymphoma, B-Cell
KW  - Rituximab
KW  - SARS-CoV-2
KW  - COVID-19 Drug Treatment
TI  - Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients With Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy: A Case Report of Two Cases.
TY  - research article
VL  - 13
ER  -